Novel APLNR antagonist candesartan induces tumor vascular normalization through ROS/cGAS/STING axis and augmented sunitinib response in breast cancer.

ABSTRACT:

SUBMITTER: Liang C 

PROVIDER: S-EPMC12763877 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature